These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7799393)

  • 41. Topical agents in the treatment of rheumatic pain.
    Moore RA; Derry S; McQuay HJ
    Rheum Dis Clin North Am; 2008 May; 34(2):415-32. PubMed ID: 18638684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
    Bolten WW
    MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The placebo responder rate in children and adolescents.
    Lewis DW; Winner P; Wasiewski W
    Headache; 2005 Mar; 45(3):232-9. PubMed ID: 15836598
    [No Abstract]   [Full Text] [Related]  

  • 44. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonsteroidal anti-inflammatory drugs during pregnancy.
    Ostensen M
    Scand J Rheumatol Suppl; 1998; 107():128-32. PubMed ID: 9759151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Fenn GC; Grobler M; Schaffer D
    Intern Med J; 2004 Nov; 34(11):647-9; discussion 650. PubMed ID: 15546461
    [No Abstract]   [Full Text] [Related]  

  • 48. [Individualized therapy in treatment of rheumatic diseases].
    Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2449-50. PubMed ID: 17156668
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of nonsteroidal antiinflammatory drugs in rheumatic diseases.
    Spector R
    J Iowa Med Soc; 1981 Dec; 71(12):538-9, 542. PubMed ID: 6977004
    [No Abstract]   [Full Text] [Related]  

  • 51. Interpreting clinical trials of antirheumatic drug therapy.
    Bellamy N; Buchanan WW
    Bull Rheum Dis; 1986; 36(2):1-10. PubMed ID: 3493823
    [No Abstract]   [Full Text] [Related]  

  • 52. [Antiphlogistic agents].
    Kogstad O
    Scand J Rheumatol Suppl; 1979; (30):262-4. PubMed ID: 317688
    [No Abstract]   [Full Text] [Related]  

  • 53. [Indications for non-steroidal anti-inflammatory agents].
    Bisson M; Couzinet B; Hiesse C; Le Pajolec C
    Rev Prat; 1987 Oct; 37(41):2500-6. PubMed ID: 3500498
    [No Abstract]   [Full Text] [Related]  

  • 54. [Brufen on the eve of the 21st century].
    Karateev DE
    Ter Arkh; 1998; 70(12):78-80. PubMed ID: 10067261
    [No Abstract]   [Full Text] [Related]  

  • 55. Are better endpoints and better design of clinical trials needed?
    Fransen J; van Riel PL
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):97-109. PubMed ID: 15123040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conspectus: Rheumatic therapeutics today.
    Roth SH
    Compr Ther; 1986 Sep; 12(9):3-9. PubMed ID: 3490350
    [No Abstract]   [Full Text] [Related]  

  • 57. [What shall we do with the numerous new anti-rheumatics?].
    Hvidberg E
    Ugeskr Laeger; 1981 Apr; 143(16):1040-3. PubMed ID: 6972112
    [No Abstract]   [Full Text] [Related]  

  • 58. [What are the indications for non-steroidal anti-inflammatory agents in dermatology?].
    Bonnetblanc JM
    Ann Dermatol Venereol; 1999; 126(8-9):649-52. PubMed ID: 10530363
    [No Abstract]   [Full Text] [Related]  

  • 59. [Findings on the causes and mechanisms in the development of undesirable effects of non-steroidal anti-rheumatic agents and their incidence in controlled clinical trials].
    Pavelka K; Vojtísek D; Kañkova D; Perlík F; Pelísková Z
    Fysiatr Revmatol Vestn; 1982 Jan; 60(1):1-10. PubMed ID: 7040188
    [No Abstract]   [Full Text] [Related]  

  • 60. [Workshop 88. Perspectives on topical therapy using non-steroidal antiphlogistics/analgesics. Frankfurt/Main, 23 January 1988].
    Z Rheumatol; 1988; 47(6 Suppl):1-12. PubMed ID: 3265560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.